Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation

Vaccine

Volumn 23, Issue 3, 2004, Pages 362-365

  Posthouwer, D ^a   Voorbij, H A M ^a   Grobbee, D E ^a   Numans, M E ^a   Van Der Bom, J G ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; Influenza vaccine; Pneumococcal vaccine

Indexed keywords

C REACTIVE PROTEIN; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PROTHROMBIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; INFLAMMATION; INFLUENZA VACCINATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

AGED; C-REACTIVE PROTEIN; DRUG COMBINATIONS; FEMALE; HUMANS; INFLAMMATION; INFLUENZA VACCINES; MALE; MODELS, BIOLOGICAL; PNEUMOCOCCAL VACCINES; VACCINATION;

EID: 7744225224     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.05.035     Document Type: Article

References (22)

1. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 1999 340
2. P. Libby Inflammation in atherosclerosis Nature 2002 420
3. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
4. J.L. Young, P. Libby, and U. Schonbeck Cytokines in the pathogenesis of atherosclerosis Thromb. Haemost. 88 2002 554 567
5. A.D. Hingorani, J. Cross, and R.K. Kharbanda Acute systemic inflammation impairs endothelium-dependent dilatation in humans Circulation 102 2000 994 999
6. R.K. Kharbanda, B. Walton, and M. Allen Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin Circulation 105 2002 2600 2604
7. F. Tomai, F. Crea, and A. Gaspardone Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion Circulation 104 2001 1471 1476
8. G.J. Blake, and P.M. Ridker Inflammatory bio-markers and cardiovascular risk prediction J. Intern. Med. 252 2002 283 294
9. E. Kazmierczak, M. Sobieska, M. Kazmierczak, A. Mrozikiewicz, and K. Wiktorowicz Intense acute phase response in ischemic patients Int. J. Cardiol. 68 1999 69 73
10. W. Koenig, M. Sund, and M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992 Circulation 99 1999 237 242
11. K. Yasojima, C. Schwab, E.G. McGeer, and P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am. J. Pathol. 158 2001 1039 1051
12. M.T. van der Beek, L.G. Visser, and M.P. de Maat Yellow fever vaccination as a model to study the response to stimulation of the inflammation system Vascul. Pharmacol. 39 2002 117 121
13. E. van Exel, J. Gussekloo, A.J. de Craen, A. Bootsma-van der Wiel, M. Frolich, and R.G. Westendorp Inflammation and stroke: the Leiden 85-Plus Study Stroke 33 2002 1135 1138
14. J.F. Doherty, M.H. Golden, J.G. Raynes, G.E. Griffin, and K.P. McAdam Acute-phase protein response is impaired in severely malnourished children Clin. Sci. (Lond.) 84 1993 169 175
15. N.S. Doherty, B.H. Littman, K. Reilly, A.C. Swindell, J.M. Buss, and N.L. Anderson Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis Electrophoresis 19 1998 355 363
16. O. Elkayam, D. Paran, and D. Caspi Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus Clin. Infect. Dis. 34 2002 147 153
17. B. Pozzetto, M.F. Odelin, J. Bienvenu, M. Defayolle, and M. Aymard Is there a relationship between malnutrition, inflammation, and post-vaccinal antibody response to influenza viruses in the elderly? J. Med. Virol. 41 1993 39 43
18. K. Raaska, V. Raitasuo, and P.J. Neuvonen Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia Eur. J. Clin. Pharmacol. 57 2001 705 708
19. P. Tarjan, S. Sipka, and L. Marodi No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus Scand. J. Rheumatol. 31 2002 211 215
20. R.P. Tracy, R.N. Lemaitre, and B.M. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler. Thromb. Vasc. Biol. 17 1997 1121 1127
21. P.M. Ridker High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 103 2001 1813 1818
22. W.L. Roberts, L. Moulton, and T.C. Law Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 Clin. Chem. 47 2001 418 425